GSK has made another investment in its manufacturing network, setting aside $800 million to build two plants at its Marietta site in the US. The programme represents the largest capital spend by ...

The funding, which brings GSK’s expenditure in US manufacturing capabilities close to $1.3bn, will establish a new vaccines ...

Sanofi unveiled a plan to build a $1 billion manufacturing site in Beijing while completing construction at a plant in ...

The partnership revolves around Muna Therapeutics’ technology platform, which employs a spatial multi-omics approach to ...

GSK has penned another neuroscience pact, this time with Danish biotech Muna Therapeutics. | GSK has penned another ...

The biotech also said it will expand the dataset it has derived from brain tissue samples. Once the companies are satisfied ...

GSK, Gilead and Arcellx, Vertex and more present new data at the American Society of Hematology annual meeting just as sickle cell therapies Casgevy and Lyfgenia have a new outcomes-based payment ...

With that in mind, GSK is partnering with developer Reef and investor UBS Asset Management to build a 1.4M SF, £900M life ...

GSK’s Withdrawn Blood Cancer Drug Paves Path Back to Market Blenrep reduced risk of death in trial, said British drugmaker GSK predicts annual sales of over £3 billion if approved ...

GSK PLCGSK3.09%increase; green up pointing triangle extended its collaboration with Chongqing Zhifei Biological Products 300122-1.12%decrease; red down pointing triangle to commercialize its ...